News

BÜHLMANN anti-MAG Autoantibodies ELISA recommended by the revised Chronic Inflammatory Demyelinating Polyneuropathy 2021 guidelines

BÜHLMANN highlights at ECCO 2021

Successful use of the FREND™ COVID-19 Ag Test at Covid Pilot Startup Days 2021 in Bern

Successful evaluation of the BÜHLMANN fPELA® turbo test at Dianalabs in Geneva